Enhancing lycopene production in Bacillus subtilis by overcoming a critical enzymatic bottleneck
Open Access
- 29 August 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1670015
Abstract
Bacillus subtilis a Generally Recognized As Safe (GRAS) microorganism, is an attractive chassis for producing high-value compounds in a safe and sustainable way. However, its potential for producing the C40 carotenoid lycopene has been limited by inefficient precursor supply and enzyme incompatibility. This study demonstrates that lycopene production in B. subtilis can be significantly enhanced through systematic metabolic engineering by rewiring the lycopene and methylerythritol phosphate (MEP) pathways. A synthetic lycopene biosynthesis pathway expressing the crtE gene from Pantoea agglomerans, which is commonly used for microbial lycopene production, failed to yield lycopene production in B. subtilis. However, replacing crtE with a multifunctional geranylgeranyl diphosphate synthase (GGPPS) from Archaeoglobus fulgidus successfully enabled lycopene synthesis. The optimization of the fermentation medium demonstrated that a combined carbon supply of glucose and glycerol markedly enhanced both cell growth and lycopene production in comparison with separate carbon sources. To further boost production, the methylerythritol phosphate (MEP) pathway was engineered by overexpressing the rate-limiting enzyme, 1-deoxy-D-xylulose-5-phosphate synthase (dxs), which resulted in a five-fold increase in lycopene titer after 72 h. Screening of various GGPPS enzymes revealed that idsA from Corynebacterium glutamicum was the most efficient, further increasing the yield. The final engineered strain achieved a lycopene titer of 55 mg/L in shake-flask cultivation, a significant improvement over the previously reported level in B. subtilis. These results demonstrate that targeted GGPPS selection and precursor pathway engineering are critical strategies for developing B. subtilis into a robust and sustainable platform for carotenoid production.Keywords
This publication has 22 references indexed in Scilit:
- Combinatorial metabolic engineering of Bacillus subtilis for menaquinone‐7 biosynthesisBiotechnology and Bioengineering, 2024
- Remodeling Isoprene Pyrophosphate Metabolism for Promoting Terpenoids BioproductionEngineering, 2023
- Metabolic engineering of Bacillus subtilis for terpenoid productionApplied Microbiology and Biotechnology, 2015
- Enhanced C30 carotenoid production in Bacillus subtilis by systematic overexpression of MEP pathway genesApplied Microbiology and Biotechnology, 2015
- Developing Bacillus spp. as a cell factory for production of microbial enzymes and industrially important biochemicals in the context of systems and synthetic biologyApplied Microbiology and Biotechnology, 2013
- Optimization of amorphadiene synthesis in bacillus subtilis via transcriptional, translational, and media modulationBiotechnology and Bioengineering, 2013
- Carotenoid production in Bacillus subtilis achieved by metabolic engineeringBiotechnology Letters, 2009
- Enhanced lycopene production in Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonateBiotechnology and Bioengineering, 2006
- Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway inEscherichia coli enhances lycopene productionBiotechnology and Bioengineering, 2001
- Engineered isoprenoid pathway enhances astaxanthin production inEscherichia coliBiotechnology and Bioengineering, 1999